BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9498795)

  • 1. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis.
    Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL
    J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
    Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
    J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural restriction in the heavy chain CDR3 of human rheumatoid factors.
    Børretzen M; Randen I; Natvig JB; Thompson KM
    J Immunol; 1995 Oct; 155(7):3630-7. PubMed ID: 7561062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
    Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
    J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of synovial IgM rheumatoid factors (RF) for genetically engineered IgG antibodies is not affected by the method used to immortalize RF-producing B cells.
    Bonagura VR; Kwong T; Kenny T; Robbins DL; Morrison SL
    Scand J Immunol; 1999 Jan; 49(1):106-11. PubMed ID: 10023865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage.
    Børretzen M; Chapman C; Natvig JB; Thompson KM
    Eur J Immunol; 1997 Mar; 27(3):735-41. PubMed ID: 9079816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
    Zhang M; Majid A; Bardwell P; Vee C; Davidson A
    J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis.
    Milosević-Jovcić N; Cirić D; Hajduković-Dragojlović L; Mircetić V
    Rheumatology (Oxford); 2004 Sep; 43(9):1190-3. PubMed ID: 15238645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies.
    Bonagura VR; Artandi SE; Agostino N; Tao MH; Morrison SL
    DNA Cell Biol; 1992 Apr; 11(3):245-52. PubMed ID: 1567557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants.
    Sasso EH; Barber CV; Nardella FA; Yount WJ; Mannik M
    J Immunol; 1988 May; 140(9):3098-107. PubMed ID: 2452199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and molecular characteristics of monoclonal IgM rheumatoid factors from arthritic and non-arthritic mice.
    Aguado MT; Balderas RS; Rubin RL; Duchosal MA; Kofler R; Birshtein BK; Secher DS; Dixon FJ; Theofilopoulos AN
    J Immunol; 1987 Aug; 139(4):1080-7. PubMed ID: 2440945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis.
    Miyata M; Sato Y; Kasukawa R
    J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal rheumatoid factor derived from rheumatoid synovial cells monospecific for rabbit IgG.
    Wong A; Kenny T; Ermel R; Robbins D
    J Rheumatol; 1993 Apr; 20(4):623-9. PubMed ID: 8496854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
    Robbins DL; Wistar R
    J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG rheumatoid factors and self-association of these antibodies.
    Mannik M; Nardella FA
    Clin Rheum Dis; 1985 Dec; 11(3):551-72. PubMed ID: 2416505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM rheumatoid factors react with human class I HLA molecules.
    Williams RC; Malone CC; Kao KJ
    J Immunol; 1996 Feb; 156(4):1684-94. PubMed ID: 8568276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing of the rheumatoid factor (RF) V gene repertoire in rheumatoid arthritis (RA) by hybridoma clones.
    Natvig JB; Randen I; Thompson K; Førre O; Mageed RA; Jefferis R; Carson DA; Tighe H; Pascual V; Victor KD
    Clin Exp Rheumatol; 1990; 8 Suppl 5():75-80. PubMed ID: 2123137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
    Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
    Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.